Research Insights ·
Brace Treatment Has a Dose, Too.

A 281-patient study involving The Hong Kong Polytechnic University, The University of Hong Kong, Kunming Medical University and Duchess of Kent Children’s Hospital found that minimum effective brace-wearing time varied with patient risk. Orthotic treatment—brace treatment—has a dose, too. [1]
1. A more personal dose of brace treatment
Published in European Spine Journal on August 8, Liu and colleagues’ retrospective study links objectively monitored wear to outcomes. At a modelled 20% curve-deterioration risk, estimated wear was 15.1 hours/day for Risser 0 versus 9.3 for Risser 1–2—different skeletal-maturity groups. That is a valuable step toward personalized dosing, requiring prospective validation before use as a prescription. [1]
2. “Brace dose” has an evidence trail
2010: Katz and colleagues reported a wear-time dose–response relationship. [2] 2013: BrAIST linked longer sensor-recorded wear with greater treatment success. [3] April 2026: Brace Dose in Scoliosis framed delivered dose through wear time, regularity and correction-related indicators. [4]
Liu’s study takes this evidence toward more individualized wearing-time estimates. [1]
3. From a prescribed dose to a measured treatment record
Drug treatment: Was it taken? Was the dose sufficient? Was the effect sufficient?
Brace treatment: Was it worn? Was it tight enough? Was the pressure sufficient?
Treatment response still requires clinical and radiographic assessment.
BraceSense solutions support these records. Based on the manufacturer’s published descriptions, they address these questions:

| Solution | Questions addressed |
|---|---|
| BraceSense | Was it worn? |
| BraceWatch | Was it worn? Was it tight enough? Was the pressure sufficient? |
| PressFilm | Was it tight enough? Was the pressure sufficient? |
| BracePress | Was the pressure sufficient? |
Translating sensor records into an individualized treatment dose still requires clinical validation.
Make brace use visible. Help precision bracing move forward.